Xiuqing Ru MD in El Segundo, California

Home California El Segundo

Xiuqing Ru MD has Hematology/oncology as her primary medical specialty. Their primary office is: 390 N Pacific Coast Hwy in El Segundo, California. There is an additional office location, for a total of two, for Xiuqing Ru MD that can be viewed further down.

They're a part of the: California Hematology Oncology Medical Group medical group which has around 5 members. You can call their office at 310-649-7222 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1985 (around 39 years of experience). They are listed as doing telehealth appointments.

Xiuqing J Ru MD Office Phone and Directions

Xiuqing Ru MD
California Hematology Oncology Medical Group
390 N Pacific Coast Hwy
El Segundo, California 90245
310-649-7222

Patient Ratings
Please rate your experience with Xiuqing Ru MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 310-649-7222

Enter a starting address:

Healthcare Info for Xiuqing Ru MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1985
The Primary Medical Specialty for Xiuqing Ru MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 7012976731
NPI #: 1679508790
NPI Created On: 07/11/2006
NPI Last Updated Listed as: 08/31/2023
Primary Taxonomy Code: 207RH0003X
License Number:
A72528
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
Injection, epoetin alfa, (for non-esrd use), 1000 units
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, palonosetron hcl, 25 mcg
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788550573

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788550575

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014363

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014367

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014371

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014377

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Additional Office Locations

1. North Platte Nebraska Hospital Corporation
601 W Leota St
North Platte, NE 69101
Great Plains Health
Group Members: 192

Phone: 310-649-7222

Enter a starting address:

Hematology/oncology Professionals in El Segundo

1.
Frank Mori

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

2.
Alex Makalinao

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

3.
Leonard Sender MD

2040 E Mariposa Ave
El-segundo, CA
Immuno-oncology Clinic Inc.

4.
Wade Nishimoto

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

5.
Mark Ngo MD

390 N Pacific Coast Hwy
El-segundo, CA
California Hematology Oncology Medical Group

Providers in California Hematology Oncology Medical Group

1.Alex Makalinao

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

2.Frank Mori

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

3.Mark Ngo Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

4.Wade Nishimoto

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

5.Xiuqing Ru Md

390 N Pacific Coast Hwy
El Segundo Ca 90245-4499
California Hematology Oncology Medical Group
Hematology/oncology

View all 5 members of California Hematology Oncology Medical Group medical group